SPY305.55+0.00 0.00%
DIA256.17+0.90 0.35%
IXIC9,485.87-66.18 -0.69%

Credit Suisse Maintains Outperform on Mednax, Lowers Price Target to $20

Credit Suisse analyst A.J. Rice maintains Mednax (NYSE:MD) with a Outperform and lowers the price target from $22 to $20.

Benzinga · 05/11/2020 12:34

Credit Suisse analyst A.J. Rice maintains Mednax (NYSE:MD) with a Outperform and lowers the price target from $22 to $20.